高通量透析联合金水宝片对糖尿病肾病血透患者血管内皮细胞生长因子及白细胞介素1β水平的影响

中华养生保健 ›› 2024, Vol. 42 ›› Issue (5): 16-18.

高通量透析联合金水宝片对糖尿病肾病血透患者血管内皮细胞生长因子及白细胞介素1β水平的影响

林小堃, 张敏, 林中方, 卢敏然

广东省中西医结合医院肾病科,广东佛山,528200

出版日期:2024-03-01 发布日期:2024-02-27
作者简介:林小堃（1987—）,女,汉族,籍贯：广东省佛山市,硕士研究生,主治医师,研究方向：肾内科。

Effect of High-Throughput Dialysis Combined with Jinshuibao Tablets on Vascular Endothelial Cell Growth Factor and Interleukin 1β Levels in Hemodialysis Patients with Diabetic Nephropathy

LIN Xiao-kun, ZHANG Min, LIN Zhong-fang, LU Min-ran

Department of Kidney disease,Guangdong Hospital of Integrated Traditional Chinese and Western Medicine, Foshan Guangdong 528200, China

Online:2024-03-01 Published:2024-02-27

摘要/Abstract

摘要： 目的研究高通量透析与口服金水宝片联合治疗对糖尿病肾透析患者血浆（vasular endothelial growth factor,VEGF）和白细胞介素-1β（interleukin-1β,IL-1β）水平的影响,以期为糖尿病肾透析患者提供新的治疗手段和思路。方法选择2021年1月—2022年6月广东省中西医结合医院收治的80例糖尿病肾病维持性血透患者为研究对象,按照随机数表法分为对照组和观察组,每组40例,两组均为低流量透析。对照组给予高通量透析（HFHD）,治疗组在高通量透析的基础上口服金水宝,3片/次（0.42 g/片）,3次/d,连续3个月,对比两组研究前后的血红蛋白（Hb）、白蛋白（Alb）、血肌酐（Scr）、尿素氮（BUN）及血浆血管内皮细胞生长因子（VEGF）、白细胞介素-1β（IL-1β）水平。结果治疗前,两组患者BUN、Scr、Hb与Alb水平比较,差异无统计学意义（P>0.05）;治疗3个月后,两组患者BUN、Scr水平均降低,Hb和Alb水平均增高,且治疗组的Hb和Alb水平高于对照组,BUN、Scr水平低于对照组,差异有统计学意义（P<0.05）。治疗前,两组患者VEGF、IL-1β水平比较,差异无统计学意义（P>0.05）;治疗3个月后,两组患者的VEGF、IL-1β水平均降低,且治疗组VEGF、IL-1β水平低于对照组,差异有统计学意义（P<0.05）。结论高通量透析治疗可改善MHD患者微炎症状态、维护其血管内皮功能,而高通量透析联合金水宝改善更明显。

关键词: 高通量血液透析, 金水宝, 血管内皮细胞生长因子, 白细胞介素1β

Abstract: Objective This study intends to use the combination of high-fluxes hemodialysis and oral Jinshuibao tablets to study the effect of high-fluxes dialysis and oral Jinshuibao tablets on plasma vasular endothelial growth factor(VEGF) and interleukin-1β (IL-1β) levels in diabetic renal dialysis patients, in order to provide new treatment methods and ideas for diabetic renal dialysis patients. Methods The random numbers of 80 patients with diabetic nephropathy maintenance hemodialysis admitted to Guangdong Hospital of Integrated Traditional Chinese and Western Medicine from January 2021 to June 2022 were divided into two groups, both of which were low-flow dialysis. At the beginning of the trial, the control group was given high- fluxes of hemodialysis (HFHD), and the treatment group took 3 tablets (0.42 g/tablet) per day, TID, for three months, hemoglobin (Hb), albumin (Alb), blood creatinine (Scr), urea nitrogen (BUN) (VEGF), interleukin-1 β (IL-1β) were compared with high-throughput dialysis. Results The levels of BUN, Scr, Hb and Alb in the blood were not significant before treatment (P>0.05); BUN and Scr decreased significantly 3 months after treatment (P<0.05), Hb and Alb increased significantly 3 months after treatment (P<0.05), and Hb and Alb in the treatment group 3 months after treatment, and BUN and Scr 3 months after treatment (P<0.05). The levels of VEGF and IL-1 β in the blood decreased significantly compared with low-throughput dialysis before the trial; VEGF and IL-1 β after 3 months of treatment in the treatment group were more prominent than in the control group (P<0.05). Conclusion High-flux dialysis can improve the micro-inflammatory state of MHD patients and maintain their vascular endothelial function. High flux dialysis combined with Jinshuibao is more obvious.

Key words: high-fluxes hemodialysis, Jinshuibao, vascular endothelial cell growth factor, interleukin 1β

中图分类号:

R692.9

林小堃, 张敏, 林中方, 卢敏然. 高通量透析联合金水宝片对糖尿病肾病血透患者血管内皮细胞生长因子及白细胞介素1β水平的影响[J]. 中华养生保健, 2024, 42(5): 16-18.

LIN Xiao-kun, ZHANG Min, LIN Zhong-fang, LU Min-ran. Effect of High-Throughput Dialysis Combined with Jinshuibao Tablets on Vascular Endothelial Cell Growth Factor and Interleukin 1β Levels in Hemodialysis Patients with Diabetic Nephropathy[J]. ZHONGHUA YANGSHENG BAOJIAN, 2024, 42(5): 16-18.

参考文献

[1] 高利东,刘佳,黄宇虹,等.基于网络药理学与分子对接技术探讨滋膵饮治疗糖尿病肾病的作用机制[J].中国中药杂志,2022,12(47):3339-3347.
[2] 青梅,包玉华,海军,等.GDF-15及IL-1β基因多态性与糖尿病肾病患者并发导管感染的关联[J].中华医院感染学杂志,2022,32(16):2448-2452.
[3] 韩淑芳,高玉琪,房洁,等.高糖状态下冠心病患者外周血中辅助性T细胞亚群失衡促进血管内皮细胞损伤[J].第三军医大学学报,2022,44(6):576-581.
[4] 马文婷,于平年,宋雪艳.血清VEGF与老年2型糖尿病肾病微血管病变相关性研究[J].中国实验诊断学,2022,26(12):1814-1815.
[5] 中华医学会糖尿病学分会微血管并发症学组.糖尿病肾病防治专家共识(2014年版)[J].中华糖尿病杂志,2014,6(11):792-801.
[6] HADJADJ S, CARIOU B, FUMERON F, et al.Death ,end -stage renal disease and renal function decline in patients with diabetic nephropathy in French cohorts of type 1 and type 2 diabetes[J]. Diabetologia,2016,59(1):208-216.
[7] 袁志娟,程志强,高会文,等.非糖尿病维持性血液透析患者血清hs-CRP、Hcy、MPO水平及其与颈动脉硬化的相关性分析[J].临床和实验医学杂志,2022,21(1):44-47.
[8] 任荣,张静,张蕾.腹膜透析与血液透析对尿毒症患者钙磷代谢、炎症细胞因子及肾纤维化指标的影响比较[J].中国中西医结合肾病杂志,2021,22(10):900-902.
[9] 王敏,李瑾.炎性细胞在动脉粥样硬化中作用的研究进展[J].中国动脉硬化杂志,2022,30(3):265-270.
[10] 刘倩,蒲萌萌,杨凯,等.不同频率血液透析滤过联合高通量血液透析治疗尿毒症的效果分析及对预后的影响[J].中国现代医学杂志,2023,33(6):71-76.
[11] RONC C, CLARK W R.Haemodialy sismembranes[J]. Nephrol,2018,14(6):394-410.
[12] 李诚孝,林丽,王艳锋.高通量血液透析与低通量血液透析对糖尿病肾病患者的影响[J].实用临床医药杂志,2021,25(7):98-101,106.
[13] STEIN G, FRANKE S, MAHIOUT A, et al.Infuence of Dialysis Mo -dalities on Serum AGE levels in End -S tage Ren al Disease Patients[J]. Nephrol Dial T ransplan t,200l,16(5):999-1008.
[14] 郭杨燕,孙行云,孟繁兴,等.血塞通注射液对OGD/R损伤小鼠脑微血管内皮细胞VEGF通路表达的影响及机制研究[J].中国医药导报,2021,18(26):12-16.
[15] 郑婕,罗娟,彭凤,等.腹膜透析患者不同腹膜转运功能与炎症因子、VEGF的相关性研究[J].检验医学与临床,2022,19(19):2617-2619.
[16] 袁甜,崔琳琳,李国玉,等.冬虫夏草中活性成分虫草素的研究进展[J].中医药信息,2020,37(6):134-139.
[17] 张静,陈元成.中成药金水宝在临床疾病中的应用概况[J].内蒙古中医药,2014,33(4):123-124.
[18] 余筱宇,余华章,陈爱春.金水宝片联合血液透析治疗52例尿毒症临床观察[J].世界最新医学信息文摘,2018,18(99):163,166.